Melisa B. Nicoud
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Differential Expression of Histamine H3 Receptor In Healthy, Preneoplastic, and Tumoral Pancreatic Tissue: A Pilot Study.
Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
Published: January 02, 2026
Design and development of nanoprobes radiolabelled with 99mTc for the diagnosis and monitoring of therapeutic interventions in oncology preclinical research.
Journal: EJNMMI radiopharmacy and chemistry
Published: July 23, 2024
Therapeutic potential of LINS01 histamine H3 receptor antagonists as antineoplastic agents for triple negative breast cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 10, 2024
Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer.
Journal: International journal of molecular sciences
Published: December 17, 2022
Histamine H4 Receptor Expression in Triple-negative Breast Cancer: An Exploratory Study.
Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
Published: March 01, 2022
Histamine in cancer immunology and immunotherapy. Current status and new perspectives.
Journal: Pharmacology research & perspectives
Published: December 11, 2020
Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model.
Journal: Cancer immunology, immunotherapy : CII
Published: June 06, 2020
Study of the antitumour effects and the modulation of immune response by histamine in breast cancer.
Study of the antitumour effects and the modulation of immune response by histamine in breast cancer.
Journal: British journal of cancer
Published: July 25, 2019
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
Journal: Frontiers in pharmacology
Published: February 26, 2019
99mTc-Radiolabeled TPGS Nanomicelles Outperform 99mTc-Sestamibi as Breast Cancer Imaging Agent.
Journal: Contrast media & molecular imaging
Published: December 07, 2018
Histamine receptors and cancer pharmacology: an update.
Journal: British journal of pharmacology
Published: July 12, 2018
Last Updated: 09/26/2026